Heat shock protein 90AB1 and hyperthermia rescue infectivity of HIV with defective cores

Virology

Volumn 436, Issue 1, 2013, Pages 162-172

  Joshi, Pheroze ^a   Sloan, Barbara ^a   Torbett, Bruce E ^b   Stoddart, Cheryl A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Capsid; HIV; HSP90AB1; Hyperthermia; Postentry

Indexed keywords

ACETYLCHOLINESTERASE; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90AB1; SUBTILISIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HYPERTHERMIA; IN VITRO STUDY; LEUKEMIA CELL LINE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPERATURE; VIRION; VIRUS CORE; VIRUS CULTURE; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS MUTATION; WESTERN BLOTTING;

CAPSID PROTEINS; CELL LINE; HEK293 CELLS; HIV; HOT TEMPERATURE; HSP90 HEAT-SHOCK PROTEINS; HUMANS; JURKAT CELLS; LEUKOCYTES, MONONUCLEAR; MUTATION; T-LYMPHOCYTES; VIRAL CORE PROTEINS;

MIRIDAE;

EID: 84872202375     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.11.005     Document Type: Article

References (40)

1. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., Martin M.A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 1986, 59(2):284-291.
2. Cantin R., Fortin J.F., Tremblay M. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. Virology 1996, 218(2):372-381.
3. Cantin R., Diou J., Belanger D., Tremblay A.M., Gilbert C. Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J. Immunol. Methods 2008, 338(1-2):21-30.
4. Carlson L.A., Briggs J.A., Glass B., Riches J.D., Simon M.N., Johnson M.C., Muller B., Grunewald K., Krausslich H.G. Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis. Cell Host Microbe 2008, 4(6):592-599.
5. Chertova E., Chertov O., Coren L.V., Roser J.D., Trubey C.M., Bess J.W., Sowder R.C., Barsov E., Hood B.L., Fisher R.J., Nagashima K., Conrads T.P., Veenstra T.D., Lifson J.D., Ott D.E. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 2006, 80(18):9039-9052.
6. Derdeyn C.A., Decker J.M., Sfakianos J.N., Wu X., O'Brien W.A., Ratner L., Kappes J.C., Shaw G.M., Hunter E. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 2000, 74(18):8358-8367.
7. Dettenhofer M., Yu X.F. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J. Virol. 1999, 73(2):1460-1467.
8. Devroe E., Silver P.A., Engelman A. HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases. Virology 2005, 331(1):181-189.
9. Dismuke D.J., Aiken C. Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex. J. Virol. 2006, 80(8):3712-3720.
10. Ellman G.L., Courtney K.D., Andres V., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
11. Forshey B.M., von Schwedler U., Sundquist W.I., Aiken C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 2002, 76(11):5667-5677.
12. Ganser-Pornillos B.K., von Schwedler U.K., Stray K.M., Aiken C., Sundquist W.I. Assembly properties of the human immunodeficiency virus type 1 CA protein. J. Virol. 2004, 78(5):2545-2552.
13. Giroud C., Chazal N., Briant L. Cellular kinases incorporated into HIV-1 particles: passive or active passengers?. Retrovirology 2011, 8:71.
14. Goff S.P. Host factors exploited by retroviruses. Nat. Rev. Microbiol. 2007, 5(4):253-263.
15. Gurer C., Cimarelli A., Luban J. Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. J. Virol. 2002, 76(9):4666-4670.
16. Jarosz D.F., Lindquist S. Hsp90 and environmental stress transform the adaptive value of natural genetic variation. Science 2010, 330(6012):1820-1824.
17. Joshi P., Stoddart C.A. Impaired infectivity of ritonavir-resistant HIV is rescued by heat shock protein 90AB1. J. Biol. Chem. 2011, 286(28):24581-24592.
18. Li J., Soroka J., Buchner J. The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones. Biochim. Biophys. Acta 2012, 1823(3):624-635.
19. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 1993, 73(6):1067-1078.
20. Nakai A., Ishikawa T. Cell cycle transition under stress conditions controlled by vertebrate heat shock factors. EMBO J. 2001, 20(11):2885-2895.
21. Ott D.E. Cellular proteins detected in HIV-1. Rev. Med. Virol. 2008, 18(3):159-175.
22. Ott D.E. Purification of HIV-1 virions by subtilisin digestion or CD45 immunoaffinity depletion for biochemical studies. Methods Mol. Biol. 2009, 485:15-25.
23. Pearl L.H., Prodromou C., Workman P. The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem. J. 2008, 410(3):439-453.
24. Powers M.V., Workman P. Inhibitors of the heat shock response: biology and pharmacology. FEBS Lett. 2007, 581(19):3758-3769.
25. Richter K., Buchner J. Closing in on the Hsp90 chaperone-client relationship. Structure 2011, 19(4):445-446.
26. Roesch F., Meziane O., Kula A., Nisole S., Porrot F., Anderson I., Mammano F., Fassati A., Marcello A., Benkirane M., Schwartz O. Hyperthermia stimulates HIV-1 replication. PLoS Pathog. 2012, 8(7):e1002792.
27. Santos S., Obukhov Y., Nekhai S., Bukrinsky M., Iordanskiy S. Virus-producing cells determine the host protein profiles of HIV-1 virion cores. Retrovirology 2012, 9(1):65.
28. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., Diaz-Griffero F., Anderson D.J., Sundquist W.I., Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. USA 2006, 103(14):5514-5519.
29. Taipale M., Jarosz D.F., Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat. Rev. Mol. Cell Biol. 2010, 11(7):515-528.
30. Tremblay M.J., Fortin J.F., Cantin R. The acquisition of host-encoded proteins by nascent HIV-1. Immunol. Today 1998, 19(8):346-351.
31. Vogt V.M. Proteolytic processing and particle maturation. Curr. Top. Microbiol. Immunol. 1996, 214:95-131.
32. von Schwedler U.K., Stray K.M., Garrus J.E., Sundquist W.I. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J. Virol. 2003, 77(9):5439-5450.
33. Wandinger S.K., Richter K., Buchner J. The Hsp90 chaperone machinery. J. Biol. Chem. 2008, 283(27):18473-18477.
34. Wei X., Decker J.M., Liu H., Zhang Z., Arani R.B., Kilby J.M., Saag M.S., Wu X., Shaw G.M., Kappes J.C. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 2002, 46(6):1896-1905.
35. Weiss A., Wiskocil R.L., Stobo J.D. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J. Immunol. 1984, 133(1):123-128.
36. Welker R., Hohenberg H., Tessmer U., Huckhagel C., Krausslich H.G. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J. Virol. 2000, 74(3):1168-1177.
37. Whitesell L., Lindquist S.L. HSP90 and the chaperoning of cancer. Nat. Rev. Cancer 2005, 5(10):761-772.
38. Wright E.R., Schooler J.B., Ding H.J., Kieffer C., Fillmore C., Sundquist W.I., Jensen G.J. Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. EMBO J. 2007, 26(8):2218-2226.
39. Yamashita M., Perez O., Hope T.J., Emerman M. Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathog. 2007, 3(10):1502-1510.
40. Yang R., Shi J., Byeon I.J., Ahn J., Sheehan J.H., Meiler J., Gronenborn A.M., Aiken C. Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects. Retrovirology 2012, 9(1):30.